Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Treasury Shares (2019 - 2025)

Historic Treasury Shares for AC Immune (ACIU) over the last 6 years, with Q3 2025 value amounting to -$272516.2.

  • AC Immune's Treasury Shares fell 830.59% to -$272516.2 in Q3 2025 from the same period last year, while for Sep 2025 it was -$272516.2, marking a year-over-year decrease of 830.59%. This contributed to the annual value of -$248851.8 for FY2024, which is 9978.98% up from last year.
  • Latest data reveals that AC Immune reported Treasury Shares of $864.3 million as of Q4 2021, which was down 9599.16% from $21.6 billion recorded in Q4 2020.
  • AC Immune's Treasury Shares' 5-year high stood at $43.2 billion during Q4 2019, with a 5-year trough of $864.3 million in Q4 2021.
  • Moreover, its 3-year median value for Treasury Shares was $21.6 billion (2020), whereas its average is $21.9 billion.
  • Its Treasury Shares has fluctuated over the past 5 years, first tumbled by 12421544.9% in 2021, then surged by 10009.57% in 2022.
  • Over the past 5 years, AC Immune's Treasury Shares (Quarter) stood at -$134.5 million in 2021, then surged by 100.1% to $128714.7 in 2022, then crashed by 92064.81% to -$118.4 million in 2023, then skyrocketed by 99.79% to -$248851.8 in 2024, then fell by 9.51% to -$272516.2 in 2025.
  • Its Treasury Shares was -$272516.2 in Q3 2025, compared to -$263320.1 in Q2 2025 and -$242470.6 in Q1 2025.